Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Correction: Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 20, 2025
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model.
Journal: European heart journal
Published: June 25, 2024
SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gαq-mice.
Journal: Journal of molecular and cellular cardiology plus
Published: June 10, 2024
SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 06, 2022
Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.
Journal: Journal of the American Heart Association
Published: June 25, 2021
Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease.
Journal: JACC. Basic to translational science
Published: March 17, 2020
A novel tracer for in vivo optical imaging of fatty acid metabolism in the heart and brown adipose tissue.
Journal: Scientific reports
Published: December 17, 2019
Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
Journal: Circulation
Published: November 27, 2019
Energetic Dysfunction Is Mediated by Mitochondrial Reactive Oxygen Species and Precedes Structural Remodeling in Metabolic Heart Disease.
Journal: Antioxidants & redox signaling
Published: May 16, 2019
Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients.
Journal: Journal of the American Heart Association
Published: April 02, 2019
Last Updated: 09/26/2026